What's new

The BJBS now holds an Impact Factor of 4.6, placing it among the top journals in its field.

IBMS supports regulatory reform proposed in Phase 2 of the Independent Inquiry into the issues raised by the David Fuller case

IBMS members took part in Pride in London and Pride Cymru in Cardiff once again this year

Promoting patient safety and best practice in transfusion care

Dermatopathology and Associated Laboratory Investigations in the Study of Skin Disease

The winners of the IBMS Awards 2025 were announced at a dazzling showcase on Friday 4th July, bringing together some of the most inspiring professionals in biomedical science for a truly unforgettable evening at The Brewery in Central London

Document clarifies the role of biomedical scientists in warfarin monitoring and dosage decisions

New report highlights solutions for earlier diagnosis

Pathology’s essential role within the wider transformation of health and care

Our new website is designed to improve how we support members, deliver qualifications and promote biomedical science.

A clear and simple way for members to track development,
reflect on learning, and stay HCPC-ready

With 320 events, a national award win & thousands reached, #BiomedicalScienceDay2025 was our biggest yet.

Announcing the #BiomedicalScienceDay2025 competition winners

A round up of the latest Biomedical Science Day activities taking place throughout the day

Congratulations to IBMS members Craig Baker, Gerta Bicaku, and Angelika Kopec on their well-deserved wins, exemplifying the highest standards of excellence and innovation in biomedical science.

Be part of our third year marching for equity, visibility and biomedical science.

A round-up of the topics discussed and decisions made at the IBMS Council meeting in April

The Health and Care Professions Council (HCPC) has announced that its proposed registration fee change has now received formal approval from both the UK and Scottish Parliaments

In this report, NHS leaders share recommendations to improve blood culture testing and reduce patient risk

IBMS, LabMed and RCPath set out a shared position on how the UK can improve oversight, clarify accountability and take a whole-system approach to managing assay performance